NATUREX : H1 2010 revenue: very sharp increase in growth

Revenue - IFRS - in ¤ million
Pre-audit figures
2009 consolidated 2009 proforma 2010 consolidated Proforma growth in constant currencies
First quarter 27.5 48.1 51.6 + 7.4 %
Second quarter 26.9 47.7 61.2 + 23.5 %
First half 54.4 95.8 112.8 + 15.4 %
Average US dollar exchange rate 1.3328 1.3328 1.3412

2009 proforma revenues include the revenues generated by the Ingredients Division of Natraceutical Group which was consolidated as of January 1, 2010.

Avignon - July 27, 2010. Naturex, global leader in specialty plant-based natural ingredients, enjoyed an excellent second quarter in 2010 marked by a very strong acceleration in growth. Revenues amounted to ¤ 61.2 million, up 127% in consolidated figures. Like-for-like, sales for the second quarter of 2010 increased 28.1% in current currencies and 23.5% in constant currencies.

Added impetus came from the smooth and ongoing integration of the Ingredients Division of Natraceutical, once again confirming the group's ability to seamlessly merge new operations.

A significant head start on forecasts

Naturex posted revenues of ¤ 112.8 million in the first half of 2010, twice the figure generated in the first six months of 2009. At constant scope and in constant currencies, sales grew 15.4%. As a result, mid-way through the year, Naturex has a clear head start on its targets for 2010 (growth of 5 to 10% like-for-like), notching up an impressive performance given the current economic backdrop.

Each of the group's divisions and geographic sectors enjoyed new growth over the first half of 2010. Food & Beverage now accounts for 59.7% of group sales, Nutrition & Health for 34.0% and Personal Care for 1.1%. Europe and Africa account for 54.0% of group activity, North and South America for 35.9%, and the Asia/Pacific region for 10.1%.

According to Jacques Dikansky, President and CEO and founder of Naturex: "This excellent start to the year has strengthened our position as the world leader in specialty plant-based ingredients - a sector with a strong market potential that is set to stay. Thanks to the investment we devote to research and development, our ability to step up the development of products with a high value-added is an invaluable asset that will continue to ensure our long-term growth".

As a reminder, Naturex will be distributing a dividend of ¤ 0.11 per share (up 10%), and shareholders have been given the option to receive their dividend in the form of shares (interested parties have between July 7 and September 10, 2010 to decide).

 Naturex will publish its results for the first half of 2010 on Tuesday 31 August after the close of trading.

If you would like to receive financial information about Naturex by e-mail, go to:

NATUREX has been listed on segment B of Euronext Paris since October 1996.

Number of shares: 6,364,000 (4,843,597 ordinary shares and 1,520,403 preferential shares).

ISIN: FR0000054694 - Reuters: NATU.PA - Bloomberg: NRX:FP.


About Naturex:

Naturex is the global leader in specialty plant-based natural ingredients. The company produces and markets natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries. The group has three strategic divisions: Food & Beverage, Nutrition & Health and Personal Care.

Naturex's sound performance is linked to the fast-growing demand for natural ingredients and its capacity to provide manufacturers with the means to meet the requirements of their end consumers. Its strength lies in its ability to position itself on specific products which constitute market niches.

Based in Avignon, the group employs around 900 people and realizes over 90% of its sales overseas. Naturex has production units across Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also has 15 sales offices located in Europe, the United States and Asia.

Naturex contacts:

Jacques Dikansky, President and CEO, Tel: +33 (0)4 90 23 96 89,

Thierry Lambert, Vice-President and CFO, Tel: +33 (0)4 90 23 96 89,

Actus contacts:

Laurence Marquézy, Investor relations, Tel: + 33 (0)1 72 74 82 23,

Anne Catherine Bonjour, Press relations, Tel: + 33 (0)1 53 67 36 93,


Revenue - IFRS - in ¤ million
Pre-audit figures
H1 2009 consolidated H1 2009 proforma H1 2010 consolidated
Europe/Africa 19.6 47.4 60.9
Americas 33.3 37.9 40.5
Asia/Pacific 1.5 10.5 11.4
Total 54.4 95.8 112.8
Revenue - IFRS - in ¤ million
Pre-audit figures
H1 2009 consolidated H1 2009 proforma H1 2010 consolidated
Food & Beverage 15.8 56.4 67.4
Nutrition & Health 35.4 35.4 38.3
Personal Care 0.6 0.6 1.2
Miscellaneous (toll extraction) 2.6 3.4 5.9
Total 54.4 95.8 112.8
Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires Communiqué intégral et original au format PDF : © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur
Receive by email the next press releases of the company by registering on, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant